Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Enveric Biosciences, Inc. (ENVB) had Return on Tangible Equity of -54.21% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.39M |
|
-- |
|
-- |
|
$1.87M |
|
$-1.87M |
|
$0.00M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.87M |
|
$-1.83M |
|
0.31M |
|
0.31M |
|
$-10.81 |
|
$-10.81 |
|
| Balance Sheet Financials | |
$4.17M |
|
$0.20M |
|
$0.20M |
|
$4.36M |
|
$0.91M |
|
-- |
|
-- |
|
$0.91M |
|
$3.46M |
|
$3.46M |
|
$3.46M |
|
0.52M |
|
| Cash Flow Statement Financials | |
$-6.36M |
|
-- |
|
$7.89M |
|
$2.24M |
|
$3.76M |
|
$1.52M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.21% |
|
|
Return on Tangible Equity |
-54.21% |
-42.95% |
|
-54.21% |
|
$6.67 |
|
$-20.29 |
|
$-20.29 |
|